Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
By asianet
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company’s high potency vial line to manufacture a commercial product. Logo – https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg “Receiving FDA approval on our HPAPI fill line is an exciting … Continued